AI-generated summary
The authors studied the effects of 890 nm laser photobiomodulation on partial tibial bone defects in rats with streptozotocin-induced type 1 diabetes, measuring stereological bone parameters and gene expression 30 days after surgery. They report that photobiomodulation increased several measures of bone volume and cell counts in diabetic rats compared with untreated diabetic controls, while also reducing osteocalcin gene expression in those rats. The study used animals, so applicability to humans is not established.
- Participants
- 48
- Who or what was studied
- Male rats with streptozotocin-induced type 1 diabetes and tibial bone defects, distributed into four groups of healthy and diabetic animals with and without photobiomodulation
- Wavelengths
- 890 nm
- Limits stated in the abstract
- The study was conducted in rats, and the abstract does not describe a human population or report human outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 890 nm
- Energy density (fluence)
- 1.5 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.